November 28, 2016 - By Linda Rogers
Penny stock shareholders are becoming inquisitive about UROLOGIX INCORPORATED (OTCMKTS:ULGX), following the fact that the share price has moved $0.00115, reaching the $0.00315 price level in a recent trade.
A big benefit of investing in small-cap shares is that there is a prospect to outpace the institutional investors. In addition, mutual funds have limits controlling their power to purchase large lots of any one firm’s outstanding shares.
It’s the latest price, but let’s analyze how the stock has been doing recently. In the past year, UROLOGIX INCORPORATED’s stock was -93.00%. According to the short interest report published recently, (ULGX) had 39,800 shorted shares for 4.5 days to cover. The prior short interest was 39,800 for a $N/A change. The 52-Week High and Low are noted here. -84.25% (High), Infinity, (Low). The stock had 8,900 average volume.
Is stock price of UROLOGIX INCORPORATED Set to Getaway to Their Potential? Register for Our Newsletter and Know the Inside Scoop!
As seen in stock market, the first point in investing in penny shares is to earn money. A popular trait of penny shares is that they move quickly and are extremely volatile. Penny shares are mainly stocks of small cap firms that can be open to change in industry conditions and stock market sentiments. Though penny shares are generally stated to be dicey, a trader can make massive amount of money in a short period of time, as against bigger, so-named ‘blue chip’ shares and mutual funds, which need a long-term plan.
Needless to state, investing in penny stock is not a right choice for the risk-averse, and only non-essential disposable income or ‘play money’ should be put in penny stocks. In no way are these stocks termed as the conservative investments and traders who play them are willing to take risks with invested capital. Penny stock shareholders must be prepared to put on stake their entire investment. Penny stocks trade fast in directions, recording massive downticks or upticks in few hours.
Receive Breaking Updates by Enrolling to our Newsletter! Hit on the Bar Below and Explore About Stocks that are Set to Make a Run!
Anticipated penny stock investors should learn and gain knowledge of the penny stock market. They must conduct intense research of a firm they might want to invest their money into. Learning can start by enrolling to a penny stock newsletter which offers informative penny stock recommendations. Gathering data as much as you can that is related to the penny stock world is tremendously vital if you want to earn money in trading. It is highly suggested that you enter into the market with a small amount of capital to lessen the risk if you incur a loss.
Disclaimer: The information, views, and opinions expressed in this publication are those of the writers and do not necessarily shows the position or official policy of any company financial professionals, analysts or stakeholders. Examples of assessment performed within this publication are just examples. They should not be used to make financial decisions or stock portfolio as they are based merely on open source and limited information. Assumptions taken within the study are not indicative of the position of any financial professionals or analysts.
More notable recent 21st North Inc (OTCMKTS:ULGX) news were published by: Globenewswire.com which released: “21st North Inc. (formerly known as Urologix, Inc.) Announces Expected Timeline …” on April 25, 2016, also Globenewswire.com with their article: “21st North Inc. Announces Special Meeting of Shareholders to Approve the Plan …” published on March 29, 2016, Globenewswire.com published: “Urologix Announces Sale of Operating Assets to Private Company Buyer” on February 02, 2016. More interesting news about 21st North Inc (OTCMKTS:ULGX) were released by: Fortune.com and their article: “North Carolina Protests Turn Violent after Fatal Police Shooting” published on September 21, 2016 as well as Fortune.com‘s news article titled: “Ericsson Is Suffering in North America” with publication date: October 21, 2016.
21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The company has a market cap of $54,986. The Firm offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia . It currently has negative earnings. The Firm has no operations.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Linda Rogers